Keisuke Hirai, PhD, Osaka University

Affiliations: 
Takeda Chemical Industries 
Area:
Neurodegenerative diseases
Google:
"Keisuke Hirai"
Bio:

http://www.tpna.com/newsroom/press_release_detail.aspx?year=2003&articleid=88

Mean distance: 16.9 (cluster 28)
 
SNBCP
Cross-listing: Neuropathology Tree - Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Swarup V, Hinz FI, Rexach JE, et al. (2018) Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nature Medicine
Ishigaki H, Itou H, Takeshima T, et al. (2013) [Henoch-Schönlein purpura developed after radical cystectomy]. Hinyokika Kiyo. Acta Urologica Japonica. 59: 663-7
Fukumoto H, Takahashi H, Tarui N, et al. (2010) A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 11157-66
Nunomura A, Honda K, Takeda A, et al. (2006) Oxidative damage to RNA in neurodegenerative diseases. Journal of Biomedicine & Biotechnology. 2006: 82323
Zhu X, Perry G, Moreira PI, et al. (2006) Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. Journal of Alzheimer's Disease : Jad. 9: 147-53
Tateyama M, Takeda A, Onodera Y, et al. (2003) Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles. Acta Neuropathologica. 105: 581-5
Perry G, Nunomura A, Cash AD, et al. (2002) Reactive oxygen: its sources and significance in Alzheimer disease. Journal of Neural Transmission. Supplementum. 69-75
Perry G, Nunomura A, Hirai K, et al. (2002) Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radical Biology & Medicine. 33: 1475-9
Castellani R, Hirai K, Aliev G, et al. (2002) Role of mitochondrial dysfunction in Alzheimer's disease. Journal of Neuroscience Research. 70: 357-60
Kawanaka Y, Kobayashi K, Kusuda S, et al. (2002) Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines. Bioorganic & Medicinal Chemistry Letters. 12: 2291-4
See more...